CCA
PFE icon

Childress Capital Advisors’s Pfizer PFE Stock Holding History

Childress Capital Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$524K Sell
21,776
-4,703
-18% -$123K 0.09% 166
2026
Q1 		$744K Buy
26,479
+247
+0.9% +$6.58K 0.13% 114
2025
Q4 		$653K Sell
26,232
-675
-3% -$17K 0.1% 142
2025
Q3 		$686K Buy
26,907
+10,294
+62% +$254K 0.13% 122
2025
Q2 		$403K Sell
16,613
-2,459
-13% -$57.3K 0.1% 147
2025
Q1 		$483K Buy
19,072
+5,378
+39% +$141K 0.14% 107
2024
Q4 		$363K Sell
13,694
-31,257
-70% -$848K 0.1% 136
2024
Q3 		$1.3M Sell
44,951
-982
-2% -$28.6K 0.35% 50
2024
Q2 		$1.29M Buy
45,933
+29,017
+172% +$799K 0.36% 46
2024
Q1 		$469K Sell
16,916
-3,318
-16% -$92.1K 0.14% 99
2023
Q4 		$583K Buy
20,234
+436
+2% +$13.2K 0.17% 80
2023
Q3 		$643K Buy
19,798
+14,286
+259% +$505K 0.21% 71
2023
Q2 		$202K Sell
5,512
-986
-15% -$38.4K 0.09% 72
2023
Q1 		$265K Sell
6,498
-14,138
-69% -$611K 0.12% 71
2022
Q4 		$1.06M Buy
20,636
+2,073
+11% +$99.4K 0.35% 51
2022
Q3 		$825K Sell
18,563
-669
-3% -$32.5K 0.32% 60
2022
Q2 		$1.01M Buy
19,232
+1,768
+10% +$90.1K 0.4% 50
2022
Q1 		$903K Buy
17,464
+2,542
+17% +$132K 0.32% 59
2021
Q4 		$881K Sell
14,922
-2,394
-14% -$119K 0.36% 52
2021
Q3 		$744K Buy
17,316
+4,019
+30% +$178K 0.3% 64
2021
Q2 		$520K Buy
13,297
+41
+0.3% +$1.59K 0.24% 69
2021
Q1 		$480K Buy
13,256
+5,719
+76% +$203K 0.22% 89
2020
Q4 		$277K Buy
+7,537
New +$276K 0.16% 76

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Childress Capital Advisors's PFE Position: Q2 2026 in Review

Childress Capital Advisors reduced its Pfizer (PFE) stake by 18% in Q2 2026, selling an estimated $123K and leaving 21,776 shares worth $524K. The position accounts for 0.09% of the portfolio, ranked #166.

Childress Capital Advisors first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.3M in Q3 2024. 2,830 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Childress Capital Advisors held 21,776 shares of Pfizer worth $524K as of Q2 2026.
  • Childress Capital Advisors sold 4,703 Pfizer shares in Q2 2026, an estimated $123K.
  • Pfizer made up 0.09% of Childress Capital Advisors's portfolio in Q2 2026, its #166 holding.
  • Childress Capital Advisors first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
  • Childress Capital Advisors's Pfizer position peaked at $1.3M in Q3 2024.
  • 2,830 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Childress Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.